Position in GH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,707,390
+$15,694,395 QoQ
Shares Held
104,695
+28741.6% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#135
of 593 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GILDER GAGNON HOWE & CO LLC holds $154,638,628 across 4 Diagnostics & Research names. GH ranks #2 (10.2% of the industry book) .
All Filings in GH
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,707,390 | 104,695 | Shares | Sole | 2026-08-14 | |
| 2023-06-30 | $12,995 | 363 | Shares | Defined | 2023-08-14 | |
| 2021-12-31 | $416,783 | 4,167 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $750,310 | 6,002 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $763,644 | 6,149 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,223,510 | 21,117 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,062,486 | 8,244 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $975,504 | 8,727 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $729,196 | 8,988 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $713,608 | 10,253 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||